ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 108 for:    Recruiting, Not yet recruiting, Available Studies | "Hip Fractures"

Hip Fracture Observational Study (HiFit)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03184896
Recruitment Status : Not yet recruiting
First Posted : June 14, 2017
Last Update Posted : June 14, 2017
Sponsor:
Information provided by (Responsible Party):
The George Institute for Global Health, China

Brief Summary:
Hip fracture is a osteoporosis-related fracture with higher mortality, and is a major public health issue in China. The British Orthopedic Association and the British Geriatric Society have published the UK Blue Book, which summarizes current evidence and best practice in the hip fracture care and secondary prevention, but this kind of standardized practice in hip fracture care is not yet existed in China. The Blue Book standards will be used as the most contemporary evidence-based guidelines for management of hip fracture.This study is to prospectively examine the barriers and facilitators in the current management of hospital in China by comparing the Blue Book standards.

Condition or disease Intervention/treatment
Hip Fractures Procedure: Hip Fracture Surgery

Study Type : Observational
Estimated Enrollment : 700 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prospective Observational Study in Hip Fracture
Estimated Study Start Date : July 1, 2017
Estimated Primary Completion Date : October 31, 2018
Estimated Study Completion Date : April 30, 2019

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
Hip Fracture Procedure: Hip Fracture Surgery
Hip Fracture Surgery




Primary Outcome Measures :
  1. The comparison between six standards in Jishuitan Hospital and Blue Book [ Time Frame: in the past one year ]
    1. The proportion of patients who admit to orthopaedic ward from A&E within 4 hours in the past one year;
    2. The proportion of patients who are operated within 48 hours in the past one year;
    3. Incidence of pressure ulcer in the past one year;
    4. The proportion of patients who receive the assessment of orthogeriatrician in the past one year;
    5. The proportion of patients who receive osteoporosis treatment in the past one year;
    6. The proportion of patients who receive specialist falls assessment in the past one year.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who have a history of an acute injury that occurred within 90 days, and diagosed by X-ray will be recruited in this study.
Criteria

Inclusion Criteria:

Adults aged 60 years old or over; Hip fracture with X-ray-confirmed femoral neck, trochanteric or sub-trochanteric fracture; Within 90 days of a hip fracture; Willingness to sign informed consent form;

Exclusion Criteria:

Patients with pathological fractures; With terminal malignancies.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03184896


Contacts
Contact: Jing Zhang +861082800577 ext 115 zjing@georgeinstitute.org.cn

Locations
China
The George Institute Not yet recruiting
Beijing, China, 100088
Contact: Jing Zhang         
Sponsors and Collaborators
The George Institute for Global Health, China

Responsible Party: The George Institute for Global Health, China
ClinicalTrials.gov Identifier: NCT03184896     History of Changes
Other Study ID Numbers: 0281001
First Posted: June 14, 2017    Key Record Dates
Last Update Posted: June 14, 2017
Last Verified: June 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries